2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Graves Ophthalmopathy in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, XL | 1 |
He, WM | 1 |
Li, W | 1 |
Zhang, L | 1 |
Grennan-Jones, F | 1 |
Draman, MS | 1 |
Lane, C | 1 |
Morris, D | 1 |
Dayan, CM | 1 |
Tee, AR | 1 |
Ludgate, M | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Graves Ophthalmopathy
Article | Year |
---|---|
[Effects and Its Mechanism of IGF-1R on the Synthesis of Hyaluronic Acid in Orbital Fibroblasts of Thyroid Associated Ophthalmopathy].
Topics: Cells, Cultured; Chromones; Fibroblasts; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Morpholines | 2017 |
Possible targets for nonimmunosuppressive therapy of Graves' orbitopathy.
Topics: Adipogenesis; Cells, Cultured; Chromones; Drug Discovery; Gene Expression Regulation; Graves Ophthal | 2014 |